Health
Is mRNA Tech the Future of Flu Shots? Report – The Quint
While Moderna, Pfizer and Sanofi have, in recent months, initiated Phase 1 trials of mRNA-based seasonal flu vaccine candidates,…

The flexibility and speed of mRNA vaccine production also means that drug makers could wait longer to begin manufacturing starting production in May, say, instead of February, for the northern hemisphere.
This would enable them to make more informed decisions…
Continue Reading
-
Business14 hours ago
2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
Noosa News14 hours ago
Australia’s biggest sheep drive, and the young drover history forgot
-
Noosa News12 hours ago
Search for man who ‘faked death’ slowed by unusual French law
-
Business20 hours ago
Are electric vehicle stocks a good investment today?